Which choice may fit the relief you need?

What can you try before a procedure?

Easy exercise can build strength without asking the sore joint to do too much. You can begin with a few gentle minutes.

A brace may make walking or chores feel steadier while the joint settles. Changing a painful task may also ease the strain.

Ibuprofen and naproxen lower swelling and soreness, but they can clash with other pills. Please check with your doctor or pharmacist first.

If exercise causes sharp soreness, a physical therapist can change the motion or effort. You won’t need to force the painful movement.

How are cortisone and gel different?

Cortisone aims to calm irritation inside the joint and often works within days. Relief is strongest in the first one to six weeks.

Its effect is small by thirteen weeks and wasn’t clear by twenty-six weeks. Each repeat procedure needs its own careful review.

Gel, also called viscosupplementation, is thick fluid placed in the knee to act like joint fluid. Its relief may take longer to begin.

Large reviews found that gel added little or no relief over a comparison procedure. Most people wouldn’t feel the small difference seen across the group.

Cortisone may raise blood sugar, and repeated use has raised concern about cartilage loss. Gel can bring brief soreness or swelling afterward.

What are PRP and concentrated PRP?

PRP starts with your blood, which is spun until more platelets sit in less liquid. Those platelets carry growth factors found in your blood.

The aim is less soreness over later months, though research does not show rebuilt cartilage. The results don’t agree with each other.

Some reviews found better relief with PRP at six months or later. A large blinded trial found no clear gain over saline at twelve months.

Concentrated PRP isn’t one standard recipe that differs from all other PRP. Its name won’t tell you the number of platelets.

Bone marrow concentrate starts with marrow drawn from the pelvis and then spun before joint care. You’d have two separate needle procedures.

A 2024 review found improvement, yet it didn’t beat other choices by an amount most people would feel. The supporting research is still rather thin.

What does an ultrasound guided knee injection change?

Ultrasound lets the doctor watch the needle enter the intended part of your joint. It can make the placement more accurate.

Putting the needle in the right spot doesn’t promise lasting relief. The medicine or prepared blood must still help.

You’re welcome to ask why guidance fits your joint and what soreness may follow. Please also ask which changes call for help.

Sources

1. The 2015 Cochrane review of 27 trials (1,767 participants) found intra-articular corticosteroid better than sham for knee OA pain (SMD -0.40, 95% CI -0.58 to -0.22; NNTB 8), but the benefit decayed with time: moderate at 1-2 weeks, small at 13 weeks, and no evidence of any effect at 26 weeks. All outcomes were graded LOW quality.

   Jüni P, et al. — Intra-articular corticosteroid for knee osteoarthritis.. Cochrane Database Syst Rev, 2015. DOI: 10.1002/14651858.CD005328.pub3.

2. In a 2-year double-blind RCT of 140 patients with symptomatic knee OA and ultrasound synovitis, 40 mg intra-articular triamcinolone every 12 weeks produced significantly greater cartilage volume loss than saline (index compartment cartilage thickness change -0.21 mm vs -0.10 mm; between-group difference -0.11 mm, 95% CI -0.20 to -0.03) with no significant difference in knee pain.

   McAlindon TE, et al. — Effect of Intra-articular Triamcinolone vs Saline on Knee Cartilage Volume and Pain in Patients With Knee Osteoarthritis: A Randomized Clinical Trial.. JAMA, 2017. DOI: 10.1001/jama.2017.5283.

3. A 2022 BMJ systematic review and meta-analysis of 169 trials (21,163 participants) found viscosupplementation produced only a small pain reduction versus placebo (SMD -0.08, 95% CI -0.15 to -0.02; about -2.0 mm on a 100 mm VAS), below the minimal clinically important difference, and trial sequential analysis indicated conclusive evidence of clinical equivalence with placebo since 2009.

   Pereira TV, et al. — Viscosupplementation for knee osteoarthritis: systematic review and meta-analysis.. BMJ, 2022. DOI: 10.1136/bmj-2022-069722.

4. The RESTORE randomized trial (288 participants, leukocyte-poor PRP, 3 weekly injections) found no significant difference from saline placebo at 12 months in knee pain (-2.1 vs -1.8 points; difference -0.4, 95% CI -0.9 to 0.2) or in medial tibial cartilage volume (-1.4% vs -1.2%), with 29 of 31 secondary outcomes also showing no between-group difference.

   Bennell KL, et al. — Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis: The RESTORE Randomized Clinical Trial.. JAMA, 2021. DOI: 10.1001/jama.2021.19415.

5. The 2019 ACR/Arthritis Foundation OA guideline makes a STRONG recommendation for intra-articular glucocorticoid injection in knee OA, alongside strong recommendations for exercise, weight loss, self-management, tai chi, cane use, bracing and NSAIDs; intra-articular steroid injection for HAND OA is only conditionally recommended.

   Kolasinski SL, et al. — 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee.. Arthritis Rheumatol, 2020. DOI: 10.1002/art.41142.

6. A 2024 network meta-analysis of 48 studies (9,338 knees) at minimum 6-month follow-up ranked PRP first for pain and function (SUCRA 91.5), then BMAC (76.5) and hyaluronic acid (53.1), with corticosteroid (15.2) barely above placebo (13.7) at that time point.

   Jawanda H, et al. — Platelet-Rich Plasma, Bone Marrow Aspirate Concentrate, and Hyaluronic Acid Injections Outperform Corticosteroids in Pain and Function Scores at a Minimum of 6 Months as Intra-Articular Injections for Knee Osteoarthritis: A Systematic Review and Network Meta-analysis.. Arthroscopy, 2024. DOI: 10.1016/j.arthro.2024.01.037.

7. A 2024 systematic review of eight randomized trials (937 patients) found BMAC improved pain and function from baseline and beat hyaluronic acid on pain at 6 and 12 months, but the differences did NOT exceed the minimal clinically important difference, and no significant differences emerged against other injectables.

   Han JH, et al. — Bone Marrow Aspirate Concentrate Injections for the Treatment of Knee Osteoarthritis: A Systematic Review of Randomized Controlled Trials.. Orthop J Sports Med, 2024. DOI: 10.1177/23259671241296555.

8. A study using fluoroscopy as the reference standard confirmed that injectate placed into the suprapatellar recess under ultrasound guidance disperses into the tibiofemoral joint after a brief bout of walking, and that blinded radiologist review corroborated the interventionalist's reading of correct needle placement.

   Varlotta C, et al. — Accuracy of ultrasound-guided knee injections confirmed by fluoroscopy.. Interv Pain Med, 2023. DOI: 10.1016/j.inpm.2022.100174.

9. A clinical review of peripheral joint injections frames them as a treatment for joint-mediated pain (arthritis, tendinopathy, bursitis) that has NOT responded to conservative management, and states plainly that these injections are typically not curative - their objective is to reduce pain enough to allow physical and pharmacologic rehabilitation to work.

   Marcolina A, et al. — Peripheral Joint Injections.. Phys Med Rehabil Clin N Am, 2022. DOI: 10.1016/j.pmr.2022.01.005.